As tau is thought to interact with Aβ in AD [4], changes in tau isoform ratios and phosphorylation via Chr21-associated proteins DYRK1A [66, 67] and RCAN1 [68] could also impact Aβ plaque composition. Here, DYRK1A is linked to Alzheimer disease.